CRDL
CRDL
NASDAQ · Pharmaceuticals

Cardiol Therapeutics Inc-A

$1.42
+0.06 (+4.41%)
As of Aug 8, 10:38 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,609.9% upside
Low Target $16.80
Average Target $24.28
High Target $33.59
Current Price $1.42
Current
$1.42
Target
$24.28
$16.80 $24.28 avg $33.59
Scenario Analysis
Bear Case
$16.80
1,083.1%
Low target
Base Case
$24.28
+1,609.9%
Avg target
Bull Case
$33.59
+2,265.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.33
-39.1% from high
52-Week Low
$1.23
+15.9% from low
Target vs 52W High
$24.28
+942.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%